Quest Diagnostics is the world’s leading provider of diagnostic information services that patients and clinicians need to make better health care decisions.
More than half a million patients every day—nearly 150 million patients every year—benefit from our solutions and commitment to creating a healthier world.
We are focused on providing access to testing with our extensive capabilities and services that make testing easier and more affordable.
BRCAvantage™ combines testing expertise with extensive support services to deliver results you can trust:
“BRCAvantage™ Testing and Services: An In-Depth Discussion” is presented by Frederic Waldman, M.D., Ph.D., Medical Director, Cancer Diagnostics, Quest Diagnostics Nichols Institute, and Wendy Conlon, MS, CGC, Quest Diagnostics Nichols Institute.
Topics covered include: